nodes	percent_of_prediction	percent_of_DWPC	metapath
Methamphetamine—MAOA—panic disorder	0.328	0.402	CbGaD
Methamphetamine—ADRA2A—panic disorder	0.277	0.339	CbGaD
Methamphetamine—SLC6A4—panic disorder	0.212	0.259	CbGaD
Methamphetamine—SLC6A2—locus ceruleus—panic disorder	0.00811	0.166	CbGeAlD
Methamphetamine—MAOA—locus ceruleus—panic disorder	0.00747	0.153	CbGeAlD
Methamphetamine—SLC6A2—sympathetic nervous system—panic disorder	0.00641	0.131	CbGeAlD
Methamphetamine—SLC6A2—autonomic nervous system—panic disorder	0.00431	0.0884	CbGeAlD
Methamphetamine—ADRA2A—peripheral nervous system—panic disorder	0.0022	0.0451	CbGeAlD
Methamphetamine—SLC18A1—brain—panic disorder	0.00214	0.0438	CbGeAlD
Methamphetamine—SLC18A2—brainstem—panic disorder	0.00171	0.035	CbGeAlD
Methamphetamine—SLC6A3—brainstem—panic disorder	0.00129	0.0264	CbGeAlD
Methamphetamine—SLC6A4—brainstem—panic disorder	0.00118	0.0242	CbGeAlD
Methamphetamine—Isocarboxazid—MAOA—panic disorder	0.00117	0.179	CrCbGaD
Methamphetamine—MAOB—brainstem—panic disorder	0.00112	0.023	CbGeAlD
Methamphetamine—SLC18A2—midbrain—panic disorder	0.00109	0.0223	CbGeAlD
Methamphetamine—SLC6A2—brainstem—panic disorder	0.00104	0.0213	CbGeAlD
Methamphetamine—MAOA—brainstem—panic disorder	0.000959	0.0197	CbGeAlD
Methamphetamine—SLC6A3—midbrain—panic disorder	0.000822	0.0169	CbGeAlD
Methamphetamine—SLC6A4—midbrain—panic disorder	0.000753	0.0154	CbGeAlD
Methamphetamine—Pargyline—MAOA—panic disorder	0.000752	0.115	CrCbGaD
Methamphetamine—MAOB—midbrain—panic disorder	0.000716	0.0147	CbGeAlD
Methamphetamine—SLC18A2—brain—panic disorder	0.000683	0.014	CbGeAlD
Methamphetamine—MAOA—midbrain—panic disorder	0.000611	0.0125	CbGeAlD
Methamphetamine—ADRA2C—midbrain—panic disorder	0.000588	0.012	CbGeAlD
Methamphetamine—CYP2D6—brainstem—panic disorder	0.00057	0.0117	CbGeAlD
Methamphetamine—SLC22A5—midbrain—panic disorder	0.000563	0.0115	CbGeAlD
Methamphetamine—Dexfenfluramine—SLC6A4—panic disorder	0.000544	0.0834	CrCbGaD
Methamphetamine—SLC6A3—brain—panic disorder	0.000517	0.0106	CbGeAlD
Methamphetamine—SLC22A3—brain—panic disorder	0.000486	0.00997	CbGeAlD
Methamphetamine—SLC6A4—brain—panic disorder	0.000473	0.00971	CbGeAlD
Methamphetamine—ADRA2A—midbrain—panic disorder	0.000469	0.00961	CbGeAlD
Methamphetamine—Phenylpropanolamine—MAOA—panic disorder	0.000456	0.0699	CrCbGaD
Methamphetamine—MAOB—brain—panic disorder	0.00045	0.00923	CbGeAlD
Methamphetamine—Tolazoline—ADRA2A—panic disorder	0.000441	0.0676	CrCbGaD
Methamphetamine—SLC6A2—brain—panic disorder	0.000417	0.00854	CbGeAlD
Methamphetamine—Phentermine—MAOA—panic disorder	0.000406	0.0623	CrCbGaD
Methamphetamine—Phenylpropanolamine—ADRA2A—panic disorder	0.000385	0.0591	CrCbGaD
Methamphetamine—Pseudoephedrine—MAOA—panic disorder	0.000385	0.059	CrCbGaD
Methamphetamine—MAOA—brain—panic disorder	0.000384	0.00787	CbGeAlD
Methamphetamine—Selegiline—MAOA—panic disorder	0.000376	0.0576	CrCbGaD
Methamphetamine—ADRA2C—brain—panic disorder	0.000369	0.00757	CbGeAlD
Methamphetamine—SLC22A5—brain—panic disorder	0.000354	0.00725	CbGeAlD
Methamphetamine—Phenelzine—MAOA—panic disorder	0.000331	0.0508	CrCbGaD
Methamphetamine—Pseudoephedrine—ADRA2A—panic disorder	0.000326	0.0499	CrCbGaD
Methamphetamine—ADRA2A—brain—panic disorder	0.000295	0.00604	CbGeAlD
Methamphetamine—Phentermine—SLC6A4—panic disorder	0.000262	0.0402	CrCbGaD
Methamphetamine—Pseudoephedrine—SLC6A4—panic disorder	0.000248	0.0381	CrCbGaD
Methamphetamine—Benzphetamine—ADRA2A—panic disorder	0.000243	0.0372	CrCbGaD
Methamphetamine—MAOB—Biological oxidations—MAOA—panic disorder	0.000234	0.00184	CbGpPWpGaD
Methamphetamine—SLC6A2—NRF2 pathway—SLC6A4—panic disorder	0.000233	0.00183	CbGpPWpGaD
Methamphetamine—ADRA2C—Integration of energy metabolism—ADRA2A—panic disorder	0.000229	0.0018	CbGpPWpGaD
Methamphetamine—CYP2D6—brain—panic disorder	0.000228	0.00468	CbGeAlD
Methamphetamine—SLC6A4—Circadian rythm related genes—CRH—panic disorder	0.000226	0.00178	CbGpPWpGaD
Methamphetamine—MAOA—SIDS Susceptibility Pathways—HTR1A—panic disorder	0.000219	0.00172	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling by GPCR—RGS2—panic disorder	0.000215	0.00169	CbGpPWpGaD
Methamphetamine—TAAR1—GPCR downstream signaling—CCK—panic disorder	0.000214	0.00168	CbGpPWpGaD
Methamphetamine—MAOA—SIDS Susceptibility Pathways—SLC6A4—panic disorder	0.000211	0.00166	CbGpPWpGaD
Methamphetamine—SLC6A3—NRF2 pathway—SLC6A4—panic disorder	0.000207	0.00163	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCRs, Class A Rhodopsin-like—CCKBR—panic disorder	0.000205	0.00161	CbGpPWpGaD
Methamphetamine—SLC18A2—Transmission across Chemical Synapses—COMT—panic disorder	0.000204	0.00161	CbGpPWpGaD
Methamphetamine—SLC18A2—Transmission across Chemical Synapses—MAOA—panic disorder	0.000203	0.00159	CbGpPWpGaD
Methamphetamine—Amphetamine—SLC6A4—panic disorder	0.000201	0.0309	CrCbGaD
Methamphetamine—TAAR1—GPCR downstream signaling—ADORA2A—panic disorder	0.000199	0.00156	CbGpPWpGaD
Methamphetamine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—NPSR1—panic disorder	0.000197	0.00155	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling by GPCR—CCK—panic disorder	0.000194	0.00153	CbGpPWpGaD
Methamphetamine—SLC6A4—SIDS Susceptibility Pathways—MAOA—panic disorder	0.000194	0.00152	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCRs, Class A Rhodopsin-like—CCKBR—panic disorder	0.000192	0.00151	CbGpPWpGaD
Methamphetamine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—NPSR1—panic disorder	0.000184	0.00145	CbGpPWpGaD
Methamphetamine—SLC6A4—Circadian rythm related genes—HTR7—panic disorder	0.000184	0.00145	CbGpPWpGaD
Methamphetamine—TAAR1—GPCR ligand binding—HTR2A—panic disorder	0.000181	0.00142	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling by GPCR—ADORA2A—panic disorder	0.00018	0.00142	CbGpPWpGaD
Methamphetamine—TAAR1—GPCR downstream signaling—CRH—panic disorder	0.000179	0.00141	CbGpPWpGaD
Methamphetamine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CCKBR—panic disorder	0.000176	0.00138	CbGpPWpGaD
Methamphetamine—TAAR1—GPCR downstream signaling—HTR1A—panic disorder	0.000172	0.00135	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—NPSR1—panic disorder	0.000165	0.0013	CbGpPWpGaD
Methamphetamine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CCKBR—panic disorder	0.000164	0.00129	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling by GPCR—CRH—panic disorder	0.000163	0.00128	CbGpPWpGaD
Methamphetamine—TAAR1—GPCR downstream signaling—ADRA2A—panic disorder	0.000159	0.00125	CbGpPWpGaD
Methamphetamine—SLC6A4—SIDS Susceptibility Pathways—HTR2A—panic disorder	0.000158	0.00124	CbGpPWpGaD
Methamphetamine—SLC18A2—Neuronal System—COMT—panic disorder	0.000157	0.00123	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling by GPCR—HTR1A—panic disorder	0.000157	0.00123	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCRs, Class A Rhodopsin-like—CCKBR—panic disorder	0.000156	0.00122	CbGpPWpGaD
Methamphetamine—SLC18A2—Neuronal System—MAOA—panic disorder	0.000156	0.00122	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR ligand binding—NPSR1—panic disorder	0.00015	0.00118	CbGpPWpGaD
Methamphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—NPSR1—panic disorder	0.00015	0.00118	CbGpPWpGaD
Methamphetamine—ADRA2C—Regulation of insulin secretion—INS—panic disorder	0.000149	0.00117	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCRs, Class A Rhodopsin-like—ADORA2A—panic disorder	0.000148	0.00117	CbGpPWpGaD
Methamphetamine—MAOA—Biological oxidations—COMT—panic disorder	0.000148	0.00116	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—CCKBR—panic disorder	0.000147	0.00116	CbGpPWpGaD
Methamphetamine—TAAR1—GPCR downstream signaling—HTR7—panic disorder	0.000146	0.00115	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling by GPCR—ADRA2A—panic disorder	0.000144	0.00113	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR ligand binding—NPSR1—panic disorder	0.00014	0.0011	CbGpPWpGaD
Methamphetamine—ADRA2B—G alpha (i) signalling events—HTR1A—panic disorder	0.000139	0.00109	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCRs, Class A Rhodopsin-like—ADORA2A—panic disorder	0.000139	0.00109	CbGpPWpGaD
Methamphetamine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CCK—panic disorder	0.000137	0.00107	CbGpPWpGaD
Methamphetamine—ADRA2B—Platelet activation, signaling and aggregation—ADRA2A—panic disorder	0.000134	0.00105	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR ligand binding—CCKBR—panic disorder	0.000134	0.00105	CbGpPWpGaD
Methamphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCKBR—panic disorder	0.000133	0.00105	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling by GPCR—HTR7—panic disorder	0.000132	0.00104	CbGpPWpGaD
Methamphetamine—MAOA—Transmission across Chemical Synapses—COMT—panic disorder	0.000131	0.00103	CbGpPWpGaD
Methamphetamine—ADRA2C—G alpha (i) signalling events—HTR1A—panic disorder	0.00013	0.00102	CbGpPWpGaD
Methamphetamine—MAOA—SIDS Susceptibility Pathways—HTR2A—panic disorder	0.000129	0.00102	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR1A—panic disorder	0.000129	0.00101	CbGpPWpGaD
Methamphetamine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CCK—panic disorder	0.000128	0.001	CbGpPWpGaD
Methamphetamine—ADRA2B—G alpha (i) signalling events—ADRA2A—panic disorder	0.000127	0.001	CbGpPWpGaD
Methamphetamine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—ADORA2A—panic disorder	0.000127	0.000998	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—RGS2—panic disorder	0.000127	0.000996	CbGpPWpGaD
Methamphetamine—ADRA2C—Platelet activation, signaling and aggregation—ADRA2A—panic disorder	0.000125	0.000983	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR ligand binding—CCKBR—panic disorder	0.000125	0.000982	CbGpPWpGaD
Methamphetamine—SLC6A3—Transmission across Chemical Synapses—COMT—panic disorder	0.000122	0.000958	CbGpPWpGaD
Methamphetamine—SLC6A3—Transmission across Chemical Synapses—MAOA—panic disorder	0.000121	0.000951	CbGpPWpGaD
Methamphetamine—ADRA2A—Regulation of insulin secretion—INS—panic disorder	0.000121	0.00095	CbGpPWpGaD
Methamphetamine—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—panic disorder	0.00012	0.000946	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR1A—panic disorder	0.00012	0.000944	CbGpPWpGaD
Methamphetamine—ADRA2C—G alpha (i) signalling events—ADRA2A—panic disorder	0.000119	0.000936	CbGpPWpGaD
Methamphetamine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—ADORA2A—panic disorder	0.000119	0.000932	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCRs, Class A Rhodopsin-like—ADRA2A—panic disorder	0.000118	0.00093	CbGpPWpGaD
Methamphetamine—ADRA2C—Integration of energy metabolism—INS—panic disorder	0.000117	0.000919	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—CCK—panic disorder	0.000115	0.000901	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR ligand binding—NPSR1—panic disorder	0.000114	0.000895	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCRs, Class A Rhodopsin-like—ADORA2A—panic disorder	0.000113	0.000884	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCRs, Class A Rhodopsin-like—ADRA2A—panic disorder	0.000111	0.000868	CbGpPWpGaD
Methamphetamine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR1A—panic disorder	0.00011	0.000866	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR7—panic disorder	0.000109	0.000855	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—ADORA2A—panic disorder	0.000107	0.000838	CbGpPWpGaD
Methamphetamine—ADRA2A—G alpha (i) signalling events—HTR1A—panic disorder	0.000105	0.000827	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR ligand binding—CCK—panic disorder	0.000104	0.000818	CbGpPWpGaD
Methamphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCK—panic disorder	0.000104	0.000815	CbGpPWpGaD
Methamphetamine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR1A—panic disorder	0.000103	0.000809	CbGpPWpGaD
Methamphetamine—TAAR1—GPCR downstream signaling—HTR2A—panic disorder	0.000102	0.000803	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR7—panic disorder	0.000102	0.000799	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR ligand binding—CCKBR—panic disorder	0.000102	0.000798	CbGpPWpGaD
Methamphetamine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—ADRA2A—panic disorder	0.000101	0.000796	CbGpPWpGaD
Methamphetamine—MAOA—Neuronal System—COMT—panic disorder	0.0001	0.000789	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR1A—panic disorder	9.76e-05	0.000767	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR ligand binding—CCK—panic disorder	9.72e-05	0.000764	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR ligand binding—ADORA2A—panic disorder	9.68e-05	0.00076	CbGpPWpGaD
Methamphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—ADORA2A—panic disorder	9.64e-05	0.000757	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—CRH—panic disorder	9.61e-05	0.000755	CbGpPWpGaD
Methamphetamine—ADRA2A—Integration of energy metabolism—INS—panic disorder	9.5e-05	0.000747	CbGpPWpGaD
Methamphetamine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—ADRA2A—panic disorder	9.47e-05	0.000744	CbGpPWpGaD
Methamphetamine—SLC6A3—Neuronal System—COMT—panic disorder	9.34e-05	0.000734	CbGpPWpGaD
Methamphetamine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR7—panic disorder	9.33e-05	0.000733	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling by GPCR—HTR2A—panic disorder	9.28e-05	0.000729	CbGpPWpGaD
Methamphetamine—SLC6A3—Neuronal System—MAOA—panic disorder	9.27e-05	0.000728	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—HTR1A—panic disorder	9.25e-05	0.000727	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR ligand binding—ADORA2A—panic disorder	9.04e-05	0.00071	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR ligand binding—CRH—panic disorder	8.72e-05	0.000685	CbGpPWpGaD
Methamphetamine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR7—panic disorder	8.71e-05	0.000684	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—ADRA2A—panic disorder	8.5e-05	0.000668	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—NPSR1—panic disorder	8.49e-05	0.000667	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR ligand binding—HTR1A—panic disorder	8.4e-05	0.00066	CbGpPWpGaD
Methamphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR1A—panic disorder	8.36e-05	0.000657	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR7—panic disorder	8.26e-05	0.000649	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR ligand binding—CRH—panic disorder	8.15e-05	0.00064	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—NPSR1—panic disorder	7.93e-05	0.000623	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR ligand binding—CCK—panic disorder	7.9e-05	0.00062	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR ligand binding—HTR1A—panic disorder	7.84e-05	0.000616	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—HTR7—panic disorder	7.82e-05	0.000615	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR ligand binding—ADRA2A—panic disorder	7.72e-05	0.000606	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—NPSR1—panic disorder	7.71e-05	0.000605	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2A—panic disorder	7.62e-05	0.000599	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—CCKBR—panic disorder	7.56e-05	0.000594	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR ligand binding—ADORA2A—panic disorder	7.34e-05	0.000577	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR ligand binding—ADRA2A—panic disorder	7.21e-05	0.000566	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—NPSR1—panic disorder	7.2e-05	0.000566	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR2A—panic disorder	7.12e-05	0.00056	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR ligand binding—HTR7—panic disorder	7.1e-05	0.000558	CbGpPWpGaD
Methamphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR7—panic disorder	7.08e-05	0.000556	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—CCKBR—panic disorder	7.06e-05	0.000555	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—ADRA2A—panic disorder	6.9e-05	0.000542	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—CCKBR—panic disorder	6.87e-05	0.00054	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—TPH2—panic disorder	6.65e-05	0.000523	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR ligand binding—HTR7—panic disorder	6.63e-05	0.000521	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR ligand binding—CRH—panic disorder	6.62e-05	0.00052	CbGpPWpGaD
Methamphetamine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—panic disorder	6.53e-05	0.000513	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—RGS2—panic disorder	6.5e-05	0.000511	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—ADRA2A—panic disorder	6.45e-05	0.000507	CbGpPWpGaD
Methamphetamine—CYP2D6—Biological oxidations—COMT—panic disorder	6.44e-05	0.000506	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—NPSR1—panic disorder	6.44e-05	0.000506	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—CCKBR—panic disorder	6.42e-05	0.000504	CbGpPWpGaD
Methamphetamine—CYP2D6—Biological oxidations—MAOA—panic disorder	6.4e-05	0.000502	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR ligand binding—HTR1A—panic disorder	6.37e-05	0.0005	CbGpPWpGaD
Methamphetamine—CYP2D6—Metapathway biotransformation—COMT—panic disorder	6.35e-05	0.000499	CbGpPWpGaD
Methamphetamine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—panic disorder	6.1e-05	0.000479	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—RGS2—panic disorder	6.07e-05	0.000477	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—RGS2—panic disorder	5.91e-05	0.000464	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—CCK—panic disorder	5.88e-05	0.000462	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—NPSR1—panic disorder	5.85e-05	0.000459	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—panic disorder	5.78e-05	0.000454	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—CCKBR—panic disorder	5.74e-05	0.000451	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—TPH2—panic disorder	5.63e-05	0.000442	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—RGS2—panic disorder	5.52e-05	0.000433	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—CCK—panic disorder	5.49e-05	0.000432	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—HTR2A—panic disorder	5.48e-05	0.000431	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—ADORA2A—panic disorder	5.47e-05	0.00043	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR ligand binding—HTR7—panic disorder	5.39e-05	0.000423	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—CCK—panic disorder	5.34e-05	0.00042	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—CCKBR—panic disorder	5.21e-05	0.000409	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—ADORA2A—panic disorder	5.11e-05	0.000401	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—ADRA2A—panic disorder	5.06e-05	0.000398	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—CCK—panic disorder	4.99e-05	0.000392	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR ligand binding—HTR2A—panic disorder	4.97e-05	0.000391	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—ADORA2A—panic disorder	4.97e-05	0.00039	CbGpPWpGaD
Methamphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—panic disorder	4.96e-05	0.000389	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—RGS2—panic disorder	4.93e-05	0.000388	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—CRH—panic disorder	4.93e-05	0.000387	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—HTR1A—panic disorder	4.74e-05	0.000373	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR ligand binding—HTR2A—panic disorder	4.65e-05	0.000365	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—ADORA2A—panic disorder	4.64e-05	0.000364	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—CRH—panic disorder	4.6e-05	0.000362	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—NPSR1—panic disorder	4.55e-05	0.000358	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—RGS2—panic disorder	4.48e-05	0.000352	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—CRH—panic disorder	4.48e-05	0.000352	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—CCK—panic disorder	4.46e-05	0.000351	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—HTR1A—panic disorder	4.43e-05	0.000348	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—ADRA2A—panic disorder	4.36e-05	0.000343	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—INS—panic disorder	4.35e-05	0.000342	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—HTR1A—panic disorder	4.31e-05	0.000339	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—ADRA2A—panic disorder	4.28e-05	0.000337	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—NPSR1—panic disorder	4.25e-05	0.000334	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—CRH—panic disorder	4.18e-05	0.000328	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—TPH2—panic disorder	4.18e-05	0.000328	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—ADORA2A—panic disorder	4.15e-05	0.000326	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—ADRA2A—panic disorder	4.07e-05	0.00032	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CCKBR—panic disorder	4.06e-05	0.000319	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—CCK—panic disorder	4.05e-05	0.000318	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—COMT—panic disorder	4.03e-05	0.000317	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—HTR1A—panic disorder	4.02e-05	0.000316	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—HTR7—panic disorder	4.01e-05	0.000315	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—MAOA—panic disorder	4e-05	0.000315	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—ADRA2A—panic disorder	3.96e-05	0.000311	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CCKBR—panic disorder	3.79e-05	0.000298	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR ligand binding—HTR2A—panic disorder	3.77e-05	0.000297	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—ADORA2A—panic disorder	3.77e-05	0.000296	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—HTR7—panic disorder	3.75e-05	0.000295	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—CRH—panic disorder	3.74e-05	0.000294	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—ADRA2A—panic disorder	3.7e-05	0.000291	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—HTR7—panic disorder	3.64e-05	0.000286	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—HTR1A—panic disorder	3.6e-05	0.000283	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—RGS2—panic disorder	3.49e-05	0.000274	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—NPSR1—panic disorder	3.45e-05	0.000271	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—TPH2—panic disorder	3.43e-05	0.00027	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—COMT—panic disorder	3.41e-05	0.000268	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—HTR7—panic disorder	3.4e-05	0.000267	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—CRH—panic disorder	3.4e-05	0.000267	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—MAOA—panic disorder	3.39e-05	0.000266	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—HTR1A—panic disorder	3.27e-05	0.000257	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—RGS2—panic disorder	3.26e-05	0.000256	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—ADRA2A—panic disorder	3.18e-05	0.00025	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CCK—panic disorder	3.16e-05	0.000248	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CCKBR—panic disorder	3.08e-05	0.000242	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—HTR7—panic disorder	3.04e-05	0.000239	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CCK—panic disorder	2.95e-05	0.000232	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—ADORA2A—panic disorder	2.93e-05	0.00023	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—HTR2A—panic disorder	2.81e-05	0.000221	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—TPH2—panic disorder	2.79e-05	0.000219	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—HTR7—panic disorder	2.77e-05	0.000217	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—ADORA2A—panic disorder	2.74e-05	0.000215	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—RGS2—panic disorder	2.65e-05	0.000208	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CRH—panic disorder	2.64e-05	0.000208	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—HTR2A—panic disorder	2.63e-05	0.000206	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—ADRA2A—panic disorder	2.61e-05	0.000205	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—INS—panic disorder	2.59e-05	0.000204	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—HTR2A—panic disorder	2.55e-05	0.000201	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—HTR1A—panic disorder	2.55e-05	0.0002	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—COMT—panic disorder	2.53e-05	0.000199	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CRH—panic disorder	2.47e-05	0.000194	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CCK—panic disorder	2.39e-05	0.000188	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—HTR2A—panic disorder	2.38e-05	0.000187	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—HTR1A—panic disorder	2.38e-05	0.000187	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—ADRA2A—panic disorder	2.34e-05	0.000184	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—ADORA2A—panic disorder	2.23e-05	0.000175	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—INS—panic disorder	2.19e-05	0.000172	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—ADRA2A—panic disorder	2.19e-05	0.000172	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—HTR7—panic disorder	2.15e-05	0.000169	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—HTR2A—panic disorder	2.13e-05	0.000168	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—COMT—panic disorder	2.08e-05	0.000164	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—MAOA—panic disorder	2.07e-05	0.000162	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—HTR7—panic disorder	2.01e-05	0.000158	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CRH—panic disorder	2.01e-05	0.000158	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—HTR2A—panic disorder	1.94e-05	0.000152	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—HTR1A—panic disorder	1.93e-05	0.000152	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—TPH2—panic disorder	1.82e-05	0.000143	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—COMT—panic disorder	1.69e-05	0.000133	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—MAOA—panic disorder	1.68e-05	0.000132	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—HTR7—panic disorder	1.63e-05	0.000128	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—INS—panic disorder	1.63e-05	0.000128	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—HTR2A—panic disorder	1.51e-05	0.000118	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—HTR2A—panic disorder	1.41e-05	0.000111	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—ADRA2A—panic disorder	1.38e-05	0.000109	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—INS—panic disorder	1.34e-05	0.000105	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—INS—panic disorder	1.2e-05	9.41e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—HTR2A—panic disorder	1.14e-05	8.99e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—INS—panic disorder	1.12e-05	8.79e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—COMT—panic disorder	1.1e-05	8.65e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—MAOA—panic disorder	1.09e-05	8.59e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—INS—panic disorder	1.09e-05	8.54e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—INS—panic disorder	9.09e-06	7.14e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—INS—panic disorder	7.08e-06	5.56e-05	CbGpPWpGaD
